Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Douglas Barry currently holds 43,981 shares of Tango Therapeutics, Inc. (TNGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas Barry has been a net seller of TNGX stock. They have purchased $0 and sold $34.9K worth of shares.
Douglas Barry's most recent insider trade was on Feb 7, 2024, when they sold 1,354 shares at $12.62 per share.
Douglas Barry serves as Executive at Tango Therapeutics, Inc. (TNGX). They have executed 5 insider transactions totaling $34.9K over their tenure at the company.
Douglas Barry holds the position of Executive at Tango Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Douglas Barry has shown a selling trading pattern, with $0 in total purchases and $34.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Douglas Barry was on Feb 6, 2024, when they sold $17.9K worth of TNGX shares. This transaction involved 1,422 shares at $12.56 per share.
Douglas Barry currently owns 43,981 shares of Tango Therapeutics, Inc. (TNGX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Douglas Barry's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Douglas Barry has 5 Form 4 filings on record as an insider at Tango Therapeutics, Inc..
Set alerts for Douglas Barry and 40,000+ other insiders.